ARCHIVES

Senate committee approves $1.1 billion increase for NIH.

This article is from The Cancer Letter archive.

Vol. 30 No. 37 | October 1, 2004

Download PDF Visit The Full Archive

Related Articles

Femara Better Suppressor Of Estrogen, Study Finds

February 22, 2002

Also in this 8-page issue: NCI, FDA open Web site for adverse event reporting.

April 16, 2004

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

January 28, 2005

ACCC Manual Tells How To Set Up, Run Cancer Program

August 27, 1976

Women 80 And Older Benefit From Mammography

May 30, 2008

Scripps, Sandoz Deal Becomes Case Study As NI Rethinks Sponsored Research

January 28, 1994